PsyMed Ventures
PsyMed Ventures is a community-focused fund and syndicate that provides capital and operational support to companies working on mental and brain health. The firm focuses on frontier technologies — including psychedelics and novel compounds, neurotechnology/BCI, precision neuroscience, digital therapeutics, AI-driven approaches, and new biologic modalities — and describes its mission as aligning healing, responsibility, and profitability.
PsyMed Ventures
Services
Equity investments (fund & syndicate)
Provides capital through a community-focused fund and syndicate model; lists ‘Syndicate Investments’ on the site and cites multiple portfolio companies and public exits.
Strategic and operational support
Provides hands-on operational support and growth guidance to portfolio companies, leveraging team experience in operations, growth, and startup scaling.
Technical & AI integration support
Provides AI and technical integration expertise for the fund and portfolio companies, supported by team members with AI and engineering backgrounds.
Community, network and visibility
Provides access to PsyMed’s community and visibility channels, including the Business Trip podcast and a newsletter, to connect founders with investors, operators, and researchers.
Mentorship and advisory access
Connects portfolio companies with advisors and venture partners who have domain expertise in neuroscience, psychiatry, neurotech, genomics, and commercial strategy.
Equity investments (fund & syndicate)
Provides capital through a community-focused fund and syndicate model; lists ‘Syndicate Investments’ on the site and cites multiple portfolio companies and public exits.
Strategic and operational support
Provides hands-on operational support and growth guidance to portfolio companies, leveraging team experience in operations, growth, and startup scaling.
Technical & AI integration support
Provides AI and technical integration expertise for the fund and portfolio companies, supported by team members with AI and engineering backgrounds.
Community, network and visibility
Provides access to PsyMed’s community and visibility channels, including the Business Trip podcast and a newsletter, to connect founders with investors, operators, and researchers.
Mentorship and advisory access
Connects portfolio companies with advisors and venture partners who have domain expertise in neuroscience, psychiatry, neurotech, genomics, and commercial strategy.
Portfolio
Described as a precision psychiatry drug development platform.
#Precision psychiatry drug development platform
Described as CRISPR for live biotherapeutics and bacterial products.
#CRISPR-based live biotherapeutics and bacterial products
Platform with a pipeline of 10+ programs for brain and mental health.
#Drug development platform for brain and mental health
Drug development platform focused on neurological and psychiatric disorders.
#Drug development platform for neurological and psychiatric disorders
Develops novel ketamine formulations for pain management and mental health disorders.
#Novel ketamine formulations
Microbiome therapeutics platform for neurological disease.
#Microbiome therapeutics for neurological disease
Described as a precision psychiatry drug development platform.
#Precision psychiatry drug development platform
Described as CRISPR for live biotherapeutics and bacterial products.
#CRISPR-based live biotherapeutics and bacterial products
Platform with a pipeline of 10+ programs for brain and mental health.
#Drug development platform for brain and mental health
Drug development platform focused on neurological and psychiatric disorders.
#Drug development platform for neurological and psychiatric disorders
Develops novel ketamine formulations for pain management and mental health disorders.
#Novel ketamine formulations
Microbiome therapeutics platform for neurological disease.
#Microbiome therapeutics for neurological disease